Skvarka Jan (CIK 1838042) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-18). Recent activity: Buy ZNTL (57,100 shares), Buy ZNTL (57,603 shares), Buy ZNTL (60,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Director | Buy | 57,100 | $0 |
| 2025-06-18 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Director | Buy | 57,603 | $0 |
| 2025-02-04 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Director | Buy | 60,000 | $103,200 |
Source: SEC Form 4 filings · as of 2026-06-18